Company intelligence / Profile preview

Magnum Opus International Holdings Limited

British Virgin Islands

Ownership: Private
Development stage: Other

Overview

Magnum Opus International Holdings Limited is an investment holding entity primarily involved in biotech-related deal contexts, such as cord blood and stem cells, but does not have direct operational biotech activities or a clinical pipeline.

Industry: Investors

Beyond the preview

Go deeper on Magnum Opus International Holdings Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnum Opus International Holdings Limited.

Explore the full profile